2017-12-04 22:43:27 UTC

Get Your Questions Answered on Biosimilar Therapies

Dec. 7, 2017

Join inflammatory bowel disease (IBD) experts on Dec. 11, 2017, 8-8:45 p.m. ET, for a free webinar on biosimilar therapies.

Register for our free webinar to gain insight into the evidence of currently available biosimilars for IBD and approaches to discussing biosimilars with patients. Register now.

This activity is a collaboration of the AGA Institute and the Crohn's & Colitis Foundation. Supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc.

More on Biosimilars

Advent of Biosimilar Products in US GI Practice
Get a better understanding of how biosimilars are utilized in U.S. gastroenterology practices. 

Considerations in Use of Biosimilars for GI Disorders
An overview of the safety and efficacy of biosimilar products. Biosimilar pricing and the impact of payor decisions on clinical GI practice are also explored.

More on Biosimilars

Insurance Barriers Should Not Hinder Step Therapy Treatment for IBD

Dec. 13, 2017

AGA participated in a congressional briefing to highlight the need for physician use of step therapy treatment without barriers.

Can You Explain Biosimilars to Patients?

Oct. 25, 2017

AGA is taking the lead in educating health care professionals and their patients about biosimilars and how they can play a role in IBD patient care.

Considerations in Use of Biosimilars for Gastrointestinal Disorders

July 19, 2017

Considerations in Use of Biosimilars for Gastrointestinal Disorders